What sector does Ind Swift Laboratories Lt belong to?

Ind Swift Laboratories Lt operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of INDSWFTLAB?

As of the latest available quote, INDSWFTLAB traded at ₹389.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of INDSWFTLAB?

Ind Swift Laboratories Lt has a price-to-earnings (P/E) ratio of about 57.97. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of INDSWFTLAB?

The market capitalisation of Ind Swift Laboratories Lt is approximately ₹3,351 Cr.

Is Ind Swift Laboratories Lt profitable?

For its latest reported financial year, Ind Swift Laboratories Lt recorded a net profit margin of about 6.40%.

Does INDSWFTLAB pay a dividend?

Ind Swift Laboratories Lt does not currently show a dividend yield in our data.

What is the return on equity (ROE) of INDSWFTLAB?

Ind Swift Laboratories Lt has a return on equity (ROE) of about 3.87%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of INDSWFTLAB?

Over the past 52 weeks, INDSWFTLAB has traded between a low of ₹87.15 and a high of ₹404.00.

Ind Swift Laboratories Lt

INDSWFTLAB NSE Healthcare Pharmaceuticals

₹389.00

+3.05%

Delayed · cached 15 min

Fair value analysis

INDSWFTLAB

Ind Swift Laboratories Lt

₹377.50

Close used for this calculation

₹119.19Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

21/100

Profitability6/25

Returns0/25

Balance Sheet13/25

Efficiency2/25

Growth0/25

Weak

Quality radar

Consensus fair value

₹119.19

Above FV

▼ -68.4% against the close used

Model range ₹30.47 – ₹170.29

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹30.47Fair value₹119.19Bull₹170.29

FairClose

52-week traded range

52W low ₹88.1552W high ₹388.55

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Ind Swift Laboratories Lt closed at ₹377.50, 216.7% above the consensus fair value of ₹119.19 drawn from 7 valuation models.

Financial DNA score 21/100 — Weak. P/E of 51.5x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹89.40

-76.3%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₹162.20

-57.0%

√(22.5 × EPS × BVPS)

EPS=4.77, BVPS=245.13 · outside Graham range (P/E 51.5, P/B 1.5) — asset-light, treat as a rough floor

P/E Fair Value

₹170.29

-54.9%

EPS × 35.7x (sector P/E)

EPS=4.77, Sector P/E=35.7x

EV/EBITDA

₹83.59

-77.9%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=760M

Book Value (P/B)

₹30.47

-91.9%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=245.13, ROE=3.9%, g=3%, r=10%

Reverse DCF

₹377.50

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 25.9% | Historical: 0%

Margin of Safety

₹105.47

-72.1%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=140.63, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer